Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited)

v3.22.1
Condensed Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 4,719 $ 14,553,438 $ (21,964,321) $ (7,406,164)
Beginning balance, shares at Dec. 31, 2020 4,718,714        
Stock-based compensation 290,805 290,805
Treasury stock 2,975,000 2,975,000
Stock issued with exercise of warrants $ 18 9,978 9,996
Stock issued with exercise of warrants, shares 18,412        
Net income (loss) (1,588,582) (1,588,582)
Beneficial conversion feature 636,075 636,075
Conversion of Bridge Financing $ 254 1,907,971 1,908,225
Conversion of Bridge Financing, shares 254,425        
Stock grant program vesting $ 17 (17)
Stock grant program vesting, shares 16,586        
Stock issuance related to offering, net of offering costs of $4,400,683 $ 6,210 57,693,107 57,699,317
Stock issuance related to offering, net of offering costs of $4,400,683, shares 6,210,000        
Treasury stock (2,975,000) (2,975,000)
Ending balance, value at Mar. 31, 2021 $ 11,218 75,091,357 (23,552,903) (2,975,000) 48,574,672
Ending balance, shares at Mar. 31, 2021 11,218,137        
Beginning balance, value at Dec. 31, 2021 $ 11,588 78,679,220 (22,839,988) (7,683,490) 48,167,330
Beginning balance, shares at Dec. 31, 2021 11,588,110        
Stock-based compensation 882,000 882,000
Treasury stock (3,773,177) (3,773,177)
Stock options exercised $ 5 28,792 $ 28,797
Stock Options Exercised, shares 4,555       4,555
Stock issued with exercise of warrants $ 35 (35)    
Stock issued with exercise of warrants, shares 34,863        
Net income (loss) (696,217) (696,217)
Treasury stock 3,773,177 3,773,177
Ending balance, value at Mar. 31, 2022 $ 11,628 $ 79,589,977 $ (23,536,205) $ (11,456,667) $ 44,608,733
Ending balance, shares at Mar. 31, 2022 11,627,528